Validated coagulation monitoring

The differentiated ROTEM® analysis gives information on hyperfibrinolysis, substitution requirements of fibrinogen, factors or platelets as well as dose control of heparin or protamin.

Whole picture of the coagulation process

ROTEM® measures:

  • clotting time
  • clot formation speed
  • clot firmness and lysis

in one whole blood sample.

It provides the whole picture of the coagulation process with helpful additional information to standard laboratory assays, with 2 levels of controls, internal self check and optional LIS/HIS connectivity.

The system allows total quality management!

Differential diagnosis approach

In the complex field of haemostasis, it is a particular challenge to diagnose coagulation disorders. The differential diagnosis approach provided by ROTEM® helps to identify numerous coagulopathic situations, such as hyperfibrinolysis, factor and platelet deficiency, or even different stages of disseminated intravascular coagulation (DIC).

Targeted therapy

The potential anticoagulant effects of therapeutic agents can be identified, and the influence of specific anticoagulants, such as heparin, can be assessed and monitored through specific analysis. Targeted individualized therapy with coagulation factors, based on ROTEM® diagnosis, helps to save the increasingly shortening, blood product supply.